Summary

  • US fertility startup Gameto has reportedly developed an alternative to in vitro fertilisation (IVF) which requires fewer hormone injections and can shorten the length of a treatment cycle.
  • The company’s method, called Fertilo, involves maturing eggs in a lab with the help of ovarian support cells made from stem cells, eliminating the need for up to 80% of the hormone injections required for traditional IVF.
  • Initial data from a non-peer reviewed study shows that after fertilising these eggs, the resultant embryos had a higher rate of developing normally and a higher rate of resulting in pregnancy.
  • A larger, Phase 3 trial to establish Fertilo’s efficacy is now underway in the US, with the results expected to provide an answer to whether the method could provide a genuinely less onerous alternative to traditional IVF.

By Emily Mullin

Original Article